Growth Metrics

Resmed (RMD) Share-based Compensation (2016 - 2025)

Resmed's Share-based Compensation history spans 17 years, with the latest figure at $28.9 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 27.85% year-over-year to $28.9 million; the TTM value through Dec 2025 reached $99.0 million, up 16.95%, while the annual FY2025 figure was $91.7 million, 14.31% up from the prior year.
  • Share-based Compensation reached $28.9 million in Q4 2025 per RMD's latest filing, up from $21.2 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $28.9 million in Q4 2025 to a low of $15.6 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $19.5 million, with a median of $19.2 million recorded in 2023.
  • Peak YoY movement for Share-based Compensation: dropped 5.34% in 2022, then increased 27.85% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $16.1 million in 2021, then rose by 2.25% to $16.5 million in 2022, then rose by 20.51% to $19.8 million in 2023, then rose by 14.08% to $22.6 million in 2024, then increased by 27.85% to $28.9 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Share-based Compensation are $28.9 million (Q4 2025), $21.2 million (Q3 2025), and $24.8 million (Q2 2025).